BBW
WST icon

Blue Barn Wealth’s West Pharmaceutical WST Stock Holding History

Blue Barn Wealth’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-580
Closed -$230K – 149
2024
Q1 		$230K Buy
+580
New +$215K 0.13% 114
2022
Q1 		– Sell
-468
Closed -$219K – 132
2021
Q4 		$219K Buy
+468
New +$201K 0.15% 112

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Blue Barn Wealth's WST Position: Q2 2024 in Review

Blue Barn Wealth sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 580 shares — an estimated $230K sold.

Blue Barn Wealth first reported a position in WST in Q4 2021 and held it in 2 quarters. The position peaked at $230K in Q1 2024. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • Blue Barn Wealth reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Blue Barn Wealth sold 580 West Pharmaceutical shares in Q2 2024, an estimated $230K.
  • Blue Barn Wealth first reported a position in West Pharmaceutical in Q4 2021 and held it in 2 quarters.
  • Blue Barn Wealth's West Pharmaceutical position peaked at $230K in Q1 2024.
  • 777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Blue Barn Wealth's 13F filing for Q2 2024, filed 5 Aug 2024.